Eligibility Requirements
What changed on this page. On 4 October 2026 we checked this page against Boehringer Ingelheim's own application form (PC-US-145555, September 2025). We removed Praxbind, which is not on the programme's list, and a 400% income limit that BI does not publish; replaced a "coverage gap" rule that no longer exists with the form's actual Medicare test; added the 12 listed medicines the page left out and the programme's phone number; and removed a retail price and processing times we could not source.
Confirm before you apply. Boehringer Cares Patient Assistance Program: 1-800-556-8317 (fax 1-866-851-2827). The foundation decides eligibility, not us, and nothing here is medical advice.
Covered Medications
The following medications are covered by Boehringer Ingelheim Cares Foundation:
How to Apply
- Speak with your healthcare provider about Boehringer Ingelheim Cares Foundation. Your doctor, nurse, or social worker can help determine if you qualify.
- Gather required documents: proof of income (tax return, pay stubs, or Social Security statement), valid prescription, and proof of U.S. residency.
- Submit your application online or by mail. Visit the program website below or call the program hotline for assistance.
- Wait for a decision. Approval times and delivery (to your home, your prescriber or a pharmacy) vary by programme, and the programme will tell you how your medicine will arrive.
Check If You Qualify
Use our free Assistance Finder tool to check eligibility for Boehringer Ingelheim Cares Foundation and other programs that may help reduce your medication costs.
Open Assistance FinderSources and standards behind this page
Drug coverage in the United States is governed by published rules rather than by any one insurer's summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- FDA Orange Book publishes the therapeutic-equivalence ratings that decide whether a generic may be substituted for a brand-name drug.
- FDA generic drug facts sets out what "generic equivalent" means and what a manufacturer must prove.
- CMS prescription drug coverage defines the rules a Medicare drug plan formulary must follow and how it may change mid-year.
- Medicare.gov drug coverage (Part D) states what a Part D plan is required to offer a member.
- CMS prescription drug appeals documents the coverage-determination and exception process when a drug is denied.
- Medicare Plan Compare is the official tool for checking what a specific plan charges for a specific drug at a specific pharmacy.
- Drugs@FDA is the federal database of approved drug products, which establishes whether a covered product exists and in what form.
- DailyMed carries the current FDA labeling for every marketed drug product, including approved strengths and forms.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medication is and how it is used.
- FTC report on pharmacy benefit managers documents how the middlemen between an insurer and a pharmacy shape what a plan actually covers.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how coverage and formularies work. It is not medical advice, and a reader's own plan documents and prescriber decide what applies to them.
Frequently Asked Questions
Yes, Jardiance is on the Boehringer Ingelheim Cares Foundation list. You can apply if you have no insurance, your insurance does not cover Jardiance, or you have Medicare, cannot afford it and do not qualify for Extra Help, and your household income meets the programme guidelines. Call 1-800-556-8317.
It covers Spiriva Respimat, Stiolto Respimat, Striverdi Respimat, Combivent Respimat and Atrovent HFA. Spiriva HandiHaler is not on the current application list.
Up to one year: the authorisation on the application expires one year from the date of enrolment, after which you reapply.
Related Resources
Get Prescription Savings Alerts
Subscribe to receive updates on patient assistance programs, drug price changes, and new savings opportunities.